Although both IL-17A and IL-17F, which belong to the IL-17 cytokine family, increased with the development of dermatitis and ankylosing enthesitis, anti-FGFR2IIIb treatment had no effect on cytokine production (Fig 5A and B). Here, IL17F is linked to dermatitis.